126 related articles for article (PubMed ID: 38670554)
21. A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells.
Kim J; Moon SH; Kim BT; Chae CH; Lee JY; Kim SH
PLoS One; 2014; 9(10):e110180. PubMed ID: 25337707
[TBL] [Abstract][Full Text] [Related]
22. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
[TBL] [Abstract][Full Text] [Related]
23. Dynamic change of TNIK in response to tumor necrosis factor alpha in a TRAF2-dependent manner.
Gui J; Li Z; Zhou X
Hum Cell; 2013 Jun; 26(2):67-72. PubMed ID: 23355318
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer.
Takahashi H; Ishikawa T; Ishiguro M; Okazaki S; Mogushi K; Kobayashi H; Iida S; Mizushima H; Tanaka H; Uetake H; Sugihara K
BMC Cancer; 2015 Oct; 15():794. PubMed ID: 26499327
[TBL] [Abstract][Full Text] [Related]
25. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study.
Zhang J; Pan Y; Shi Q; Zhang G; Jiang L; Dong X; Gu K; Wang H; Zhang X; Yang N; Li Y; Xiong J; Yi T; Peng M; Song Y; Fan Y; Cui J; Chen G; Tan W; Zang A; Guo Q; Zhao G; Wang Z; He J; Yao W; Wu X; Chen K; Hu X; Hu C; Yue L; Jiang D; Wang G; Liu J; Yu G; Li J; Bai J; Xie W; Zhao W; Wu L; Zhou C
Cancer Commun (Lond); 2022 Jan; 42(1):3-16. PubMed ID: 34699693
[TBL] [Abstract][Full Text] [Related]
27. TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton.
Fu CA; Shen M; Huang BC; Lasaga J; Payan DG; Luo Y
J Biol Chem; 1999 Oct; 274(43):30729-37. PubMed ID: 10521462
[TBL] [Abstract][Full Text] [Related]
28. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract][Full Text] [Related]
29. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
30. LKB1 loss promotes colorectal cancer cell metastasis through regulating TNIK expression and actin cytoskeleton remodeling.
Hu G; Huang N; Zhang J; Zhang D; Wang S; Zhang Y; Wang L; Du Y; Kuang S; Ma K; Zhu H; Xu N; Liu M
Mol Carcinog; 2023 Nov; 62(11):1659-1672. PubMed ID: 37449799
[TBL] [Abstract][Full Text] [Related]
31. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
[TBL] [Abstract][Full Text] [Related]
32. Structural Insight into TNIK Inhibition.
Kukimoto-Niino M; Shirouzu M; Yamada T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis.
van Os BW; Kusters PJH; den Toom M; Beckers L; van Tiel CM; Vos WG; de Jong E; Kieser A; van Roomen C; Binder CJ; Reiche ME; de Winther MP; Bosmans LA; Lutgens E
Front Cardiovasc Med; 2023; 10():1171764. PubMed ID: 37215541
[TBL] [Abstract][Full Text] [Related]
34. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
van den Bovenkamp K; van der Vegt B; Halmos GB; Slagter-Menkema L; Langendijk JA; van Dijk BAC; Schuuring E; van der Laan BFAM
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3801-3809. PubMed ID: 37029804
[TBL] [Abstract][Full Text] [Related]
35. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
Ho KK; Parnell KM; Yuan Y; Xu Y; Kultgen SG; Hamblin S; Hendrickson TF; Luo B; Foulks JM; McCullar MV; Kanner SB
Bioorg Med Chem Lett; 2013 Jan; 23(2):569-73. PubMed ID: 23232060
[TBL] [Abstract][Full Text] [Related]
36. Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction.
Chen P; Wu JN; Shu Y; Jiang HG; Zhao XH; Qian H; Chen K; Lan T; Chen CG; Li J
Clin Sci (Lond); 2018 Jul; 132(13):1417-1433. PubMed ID: 29853661
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III-IV lung squamous cell carcinoma.
Song J; Tian J; Zhang L; Qu X; Qian W; Zheng B; Zhang L; Zhao J; Niu M; Zhou M; Cui L; Liu Y; Zhao M
Eur Radiol; 2019 May; 29(5):2388-2398. PubMed ID: 30643941
[TBL] [Abstract][Full Text] [Related]
38. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
Huang L; Walter V; Hayes DN; Onaitis M
Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
[TBL] [Abstract][Full Text] [Related]
39. The Ste20 Family Kinases MAP4K4, MINK1, and TNIK Converge to Regulate Stress-Induced JNK Signaling in Neurons.
Larhammar M; Huntwork-Rodriguez S; Rudhard Y; Sengupta-Ghosh A; Lewcock JW
J Neurosci; 2017 Nov; 37(46):11074-11084. PubMed ID: 28993483
[TBL] [Abstract][Full Text] [Related]
40. LUBAC determines chemotherapy resistance in squamous cell lung cancer.
Ruiz EJ; Diefenbacher ME; Nelson JK; Sancho R; Pucci F; Chakraborty A; Moreno P; Annibaldi A; Liccardi G; Encheva V; Mitter R; Rosenfeldt M; Snijders AP; Meier P; Calzado MA; Behrens A
J Exp Med; 2019 Feb; 216(2):450-465. PubMed ID: 30642944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]